by Sonya Goins Credit: Unsplash/CC0 Public Domain The myth that people with dark skin are immune to melanoma, a type of skin cancer, has persisted for many years. It’s a dangerous misconception that has caused some people not to be diligent about protecting themselves against dangerous UV rays. Dr. Dawn Davis , a Mayo Clinic...
Tag: <span>MELANOMA</span>
Men need to take melanoma seriously
by ByJason Howland, Mayo Clinic Credit: Mayo Clinic News Network It’s only April, but many people across the country and the globe are already enjoying summerlike temperatures. But getting out in the sun also increases your risk of getting skin cancer. Melanoma is the most serious type of skin cancer. It develops in the cells that produce...
Study reveals how diet and probiotics boost melanoma immunotherapy response
by University of Pittsburgh Marlies Meisel, Ph.D., assistant professor in the Department of Immunology at the University of Pittsburgh School of Medicine and member of the Cancer Immunology and Immunotherapy Program at UPMC Hillman Cancer Center. Credit: Marlies Meisel In mice with melanoma, probiotic bacteria travel from the gut and establish in tumors, where they...
Melanoma: Vitamin D supplements linked to reduced skin cancer risk
A recent study observed that people who regularly took vitamin D supplements were less likely to have melanoma. Marc Tran/Stocksy A new cross-sectional study observed that people who regularly took vitamin D supplements were less likely to have melanoma, a form of skin cancer, than those who did not take supplements. The researchers’ analysis also...
Fewer cases of melanoma among people taking vitamin D supplements
UNIVERSITY OF EASTERN FINLAND Fewer cases of melanoma were observed among regular users of vitamin D supplements than among non-users, a new study finds. People taking vitamin D supplements regularly also had a considerably lower risk of skin cancer, according to estimates by experienced dermatologists. The study, conducted in collaboration between the University of Eastern...
Patient’s own immune cells effective as living medicine for melanoma
by Netherlands Cancer Institute Preparing tumor-infiltrating lymphocyte therapy for melanoma patients in the lab. Credit: NKI A patient’s own immune cells, multiplied into an army of billions of immune cells in a lab, can be used as a living medicine against metastatic melanoma, an aggressive form of skin cancer, as the TIL trial has shown....
Biomarker predicts resistance to immunotherapies in melanoma
by Duke University Medical Center Schematic of the tumor-intrinsic NLRP3-HSP70 signaling axis and its role in supporting metastatic progression in the lung in response to anti-PD-1 immunotherapy. Credit: B. Theivanthiran, et al., Science Translational Medicine (2022) Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma...
Making melanoma immortal: Scientists discover key genetic step in cancer’s race to live forever
by University of Pittsburgh Human chromosomes (gray) capped by telomeres (white). Credit: PD-NASA; PD-USGOV-NASA Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. In a paper published in Science this week, Jonathan Alder, Ph.D. and his team describe how they discovered...
Reprogramming of immune cells shown to fight off melanoma
UNIVERSITY OF BRISTOL IMAGE: ILLUSTRATION SHOWING HOW MINIATURE ARTIFICIAL PROTOCELLS LOADED WITH ANTI-MICRORNA-223 CARGO CAN REPROGRAM CANCER-ASSOCIATED MACROPHAGES IN LARVAL AND ADULT ZEBRAFISH LEADING THEM TO BE MORE PRO-INFLAMMATORY AND THUS ABLE TO DRIVE MELANOMA SHRINKAGE CREDIT: PACO LOPEZ CUEVAS A new way of reprogramming our immune cells to shrink or kill off cancer cells...
Drug giant Merck teams with Moderna to develop shot for melanoma that uses patients’ own TUMORS
By CAITLIN TILLEY, HEALTH REPORTER FOR DAILYMAIL.COM PUBLISHED: 11:05 EDT, 13 October 2022 | UPDATED: 12:49 EDT, 13 October 2022 Pharma giants Merck and Moderna have teamed up to develop a cancer vaccine that is based on the same tech used in Covid shots. The new shot — designed for people with high-risk melanoma — is in the second of three trials...